## Core Concept
Tacrolimus is an immunosuppressive medication primarily used to prevent rejection in organ transplant patients. It works by inhibiting calcineurin, which is crucial for T-cell activation. The blood level of tacrolimus needs to be monitored closely because of its narrow therapeutic index.

## Why the Correct Answer is Right
The correct answer, rifampicin, is an inducer of the cytochrome P450 3A4 (CYP3A4) enzyme. Tacrolimus is metabolized by CYP3A4. When CYP3A4 is induced, it increases the metabolism of tacrolimus, leading to decreased tacrolimus levels. Therefore, rifampicin would decrease tacrolimus levels, not increase them.

## Why Each Wrong Option is Incorrect
- **Option A:** Ketoconazole is an inhibitor of CYP3A4. By inhibiting this enzyme, ketoconazole decreases the metabolism of tacrolimus, leading to increased tacrolimus levels.
- **Option B:** Erythromycin is also a CYP3A4 inhibitor. Similar to ketoconazole, it would increase tacrolimus levels by reducing its metabolism.
- **Option C:** Diltiazem inhibits CYP3A4 and can also affect the P-glycoprotein transport system, which can lead to increased tacrolimus levels.

## Clinical Pearl / High-Yield Fact
A key point to remember is that drug interactions with tacrolimus can significantly affect its blood levels, potentially leading to either toxicity or reduced efficacy. CYP3A4 inhibitors can dramatically increase tacrolimus levels, necessitating dose adjustments to prevent toxicity.

## Correct Answer Line
**Correct Answer: D. rifampicin.**